IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Orexigen Therapeutics Inc

CUSIP: 686164AC8 | 7 institutional holders

Quarters

Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

Daiwa Securities Group Inc.3,378,000
0.0% of portfolio›$236
StyleTurnoverLocationFiled
Daiwa Securities Group Inc.
3,378,000$2360.0%GrowthMediumChiyoda-Ku,Tokyo, Mexico2018-05-02